How Hykes was paid
$3.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Kevin HykesPresident and Chief Executive Officer | $660,533 | $1,270,080 | $1,516,896 | $444,492 | $13,800 | $3,905,801 |
| Robert JohnChief Revenue Officer | $485,313 | $712,800 | $389,473 | $160,998 | $13,800 | $1,762,384 |
| Philip AdamsonChief Medical Officer | $549,539 | $259,200 | $307,479 | $231,125 | $13,800 | $1,361,143 |
What changed and why
- $3.9MKevin Hykes received total compensation of $3,905,801 for fiscal 2025 compared to $8,756,626 in 2024.
- 50%The company introduced restricted stock units in 2025, weighting long-term incentives approximately 50% in stock options and 50% in RSUs.
- Annual cash incentives for NEOs were based on total revenue, U.S. revenue, modified operating loss, and key operating objectives.
- $13,800All named executive officers received $13,800 in all other compensation through 401(k) matching contributions.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.